Status | Study |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Withdrawn |
Study Name: Temozolomide in Treating Patients With Invasive Pituitary Tumors Condition: Brain and Central Nervous System Tumors Date: 2008-01-25 Interventions: Drug: temozolomide Genetic: DNA methylatio |